Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: Involvement of antioxidative enzymes induction

被引:86
|
作者
Wu, Chi-Rei [1 ]
Tsai, Chia-Wen [2 ]
Chang, Shu-Wei [3 ]
Lin, Chia-Yuan [2 ]
Huang, Li-Chun [2 ]
Tsai, Chia-Wen [2 ]
机构
[1] China Med Univ, Coll Pharm, Sch Chinese Pharmaceut Sci & Chinese Med Resource, Taichung, Taiwan
[2] China Med Univ, Dept Nutr, Taichung, Taiwan
[3] Dayeh Univ, Dept Med Bot & Hlth Care, Changhua, Taiwan
关键词
Carnosic acid; Neuroprotection; Antioxidative enzymes; Apoptosis; Wistar rats; GLUTATHIONE METABOLISM; PC12; CELLS; OXIDATIVE STRESS; SH-SY5Y CELLS; APOPTOSIS; 6-OHDA; ACTIVATION; DEATH; CONSTITUENTS; BCL-2/BAX;
D O I
10.1016/j.cbi.2014.11.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neuroprotective effects of carnosic acid (CA), a phenolic diterpene isolated from rosemary (Rosmarinus officinalis), have been widely investigated in recent years, however, its protection in in vivo still unclear. In this study, we investigated the behavioral activity and neuroprotective effects of CA in a rat model of Parkinson's disease (PD) induced by 6-hydroxydopamine (6-OHDA). Rats were treated with 20 mg/kg body weight of CA for 3 weeks before 6-OHDA exposure. Results indicated that CA improved the locomotor activity and reduced the apomorphine-caused rotation in 6-OHDA-stimulated rats. Significant protection against lipid peroxidation and GSH reduction was observed in the 6-OHDA rats pre-treated with CA. Pretreatment with CA increased the protein expression of gamma-glutamate-cysteine ligase catalytic subunit, gamma-glutamate-cysteine ligase modifier subunit, superoxide dismutase, and glutathione reductase compared with 6-OHDA-stimulated rats and SH-SY5Y cells. Immunoblots showed that the reduction of the Bcl-2/Bax ratio, the induction of caspase 3 cleavage, and the induction of poly(ADPribose) polymerase (PARP) cleavage by 6-OHDA was reversed in the presence of SB203580 (a p38 inhibitor) or SP600125 (a JNK inhibitor) in SH-SY5Y cells. Rats treated with CA reversed the 6-OHDA-mediated the activation of c-JunNH2-terminal kinase and p38, the down-regulation of the Bcl-2/Bax ratio, the up-regulation of cleaved caspase 3/caspase 3 and cleaved PARP/PARP ratio, and the down-regulation of tyrosine hydroxylase protein. However, BAM7, an activator of Bax, attenuated the effect of CA on apoptosis in SH-SY5Y cells. These results suggest that CA protected against 6-OHDA-induced neurotoxicity is attributable to its anti-apoptotic and anti-oxidative action. The present findings may help to clarify the possible mechanisms of rosemary in the neuroprotection of PD. (C) 2014 Published by Elsevier Ireland Ltd.
引用
收藏
页码:40 / 46
页数:7
相关论文
共 50 条
  • [1] Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson's Disease
    Manouchehrabadi, Mahboubeh
    Farhadi, Mona
    Azizi, Zahra
    Torkaman-Boutorabi, Anahita
    NEUROTOXICITY RESEARCH, 2020, 37 (01) : 156 - 170
  • [2] Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson’s Disease
    Mahboubeh Manouchehrabadi
    Mona Farhadi
    Zahra Azizi
    Anahita Torkaman-Boutorabi
    Neurotoxicity Research, 2020, 37 : 156 - 170
  • [3] Thymol protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson’s disease via inhibiting oxidative stress
    Saeideh Nourmohammadi
    Sanaz Yousefi
    Mahboubeh Manouchehrabadi
    Mona Farhadi
    Zahra Azizi
    Anahita Torkaman-Boutorabi
    BMC Complementary Medicine and Therapies, 22
  • [4] Thymol protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease via inhibiting oxidative stress
    Nourmohammadi, Saeideh
    Yousefi, Sanaz
    Manouchehrabadi, Mahboubeh
    Farhadi, Mona
    Azizi, Zahra
    Torkaman-Boutorabi, Anahita
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2022, 22 (01)
  • [5] A New Danshensu Derivative Protects Against 6-Hydroxydopamine-Induced Neurotoxicity In Vitro and In Vivo
    Cui, Guozhen
    Shan, Luchen
    Chen, Yang
    Zhou, Hefeng
    Wang, Yuqiang
    Lee, Simon Ming-Yuen
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2016, 44 (07): : 1349 - 1361
  • [6] SF-6 attenuates 6-hydroxydopamine-induced neurotoxicity: An in vitro and in vivo investigation in experimental models of Parkinson's disease
    Kopalli, Spandana Rajendra
    Koppula, Sushruta
    Shin, Ki Young
    Noh, Su-Jin
    Jin, Qinghao
    Hwang, Bang Yeon
    Suh, Yoo-Hun
    JOURNAL OF ETHNOPHARMACOLOGY, 2012, 143 (02) : 686 - 694
  • [7] JM-20 protects against 6-hydroxydopamine-induced neurotoxicity in models of Parkinson's disease: Mitochondrial protection and antioxidant properties
    Arturo Fonseca-Fonseca, Luis
    Amaral da Silva, Victor Diogenes
    Wong-Guerra, Maylin
    Ramirez-Sanchez, Jeney
    Padron Yaquis, Alejandro Saul
    Ochoa-Rodriguez, Estael
    Verdecia-Reyes, Yamila
    de Araujo, Fillipe Mendes
    Santana, Rejane Conceica
    Outeiro, Tiago Fleming
    Costa, Silvia Lima
    Nunez-Figueredo, Yanier
    NEUROTOXICOLOGY, 2021, 82 : 89 - 98
  • [8] Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease
    Vercammen, Linda
    Van der Perren, Anke
    Vaudano, Elisabetta
    Gijsbers, Rik
    Debyser, Zeger
    Van den Haute, Chris
    Baekelandt, Veerle
    MOLECULAR THERAPY, 2006, 14 (05) : 716 - 723
  • [9] FGF18 PROTECTS AGAINST 6-HYDROXYDOPAMINE-INDUCED NIGROSTRIATAL DAMAGE IN A RAT MODEL OF PARKINSON'S DISEASE
    Guo, Xingzhi
    Liu, Tingting
    Zhao, Diandian
    Wang, Xiaofeng
    Liu, Dongmei
    He, Yang
    Shan, Chang
    Kong, Yingying
    Hu, Weiwei
    Tao, Bei
    Sun, Lihao
    Zhao, Hongyan
    Li, Shengtian
    Liu, Jianmin
    NEUROSCIENCE, 2017, 356 : 229 - 241
  • [10] Changes in the activity of the antioxidant enzymes in 6-hydroxydopamine-induced rat model of Parkinson's disease
    Ciobica, A.
    Hritcu, L.
    Artenie, V.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 283 (1-2) : 282 - 283